EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 14 May 2024. Database contains 4691 unique substances/entries.

Filter the list

Showing 201 - 400 of 4,691 results.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)
chloro-1-ethylcyclohexyl carbonate	444-950-8	99464-83-2	Muta. 2; Skin Sens. 1
2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one	444-860-9	474510-57-1	STOT RE 2
(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone BUTAMINONITRODARONE; SR33581	444-800-1	141645-23-0	Flam. Liq. 3; Acute Tox. 4; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
(1R, 4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene	444-480-3	676125-00-1	Skin Irrit. 2
tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate	444-440-5	220689-12-3	Acute Tox. 4
(3S, 6R, 9S, 12R, 15S, 18R, 21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone	444-350-6	133413-70-4	Eye Irrit. 2
(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride	444-320-2	-	Acute Tox. 4
reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III); trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III)	444-290-0	508202-43-5	Eye Dam. 1; Skin Sens. 1
2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate	444-250-2	144111-81-9	Self-react. C
reaction mass of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)aniline]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo{naphthalene-2,7-disulfonate; trisodium 5-4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; disodium 5-4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 5-4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate	444-050-5	-	Eye Dam. 1
2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide	443-980-9	221215-20-9	Skin Sens. 1
ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate	443-870-0	163520-33-0	Acute Tox. 4; Skin Sens. 1
(2,3,5,6-tetrafluorophenyl)methanol	443-840-7	4084-38-2	Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid	443-560-5	88784-33-2	Eye Irrit. 2
trans-methyl-2-ethyl-but-2-enoate	443-150-6	101226-85-1	Flam. Liq. 3
methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate	443-120-2	393509-79-0	Eye Dam. 1
triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)	442-960-7	332350-93-3	Acute Tox. 3; Eye Dam. 1
methyl 2-(acetylamino)-3-chloropropionate	442-860-3	87333-22-0	Skin Sens. 1
1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate	442-850-9	114772-40-6	Skin Sens. 1
bifenazate (ISO); isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate	442-820-5	149877-41-8	STOT RE 2; Skin Sens. 1
reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl[}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)	442-800-6	-	Skin Irrit. 2
cobalt lithium nickel oxide	442-750-5	113066-89-0	Carc. 1A; Acute Tox. 2; STOT RE 1; Skin Sens. 1
magnesium sodium fluoride silicate	442-650-1	56450-90-9	STOT RE 2
reaction mass of: 1,2-dimethylpropylidene dihydroperoxide; dimethyl 1,2-benzenedicarboxylate	442-480-8	-	Org. Perox. C; Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl)oxo(phenyl)acetate	442-300-8	-	Skin Sens. 1
reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt; 3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt	442-290-5	457624-86-1	Eye Dam. 1
2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazophenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt	442-230-8	321679-52-1	Eye Dam. 1
pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid	442-030-0	321912-47-4	Eye Dam. 1
3,4-dihydroxy-5-nitrobenzaldehyde	441-810-8	116313-85-0	Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
6,6'-bis(diazo-5,5', 6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)	441-550-5	-	Self-react. C; Carc. 2
3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline HPDCFA	441-190-9	121451-05-6	Acute Tox. 4; Skin Sens. 1
(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile	441-070-6	61826-76-4	Acute Tox. 3; Eye Dam. 1; Skin Sens. 1
ammonium 2-cocoyloxyethanesulfonate	441-050-7	223705-57-5	Skin Irrit. 2; Eye Dam. 1
1-ethoxy-2,3-difluorobenzene 1-ETHOXY-2,3-DIFLUORBENZOL; 1-ETHOXY-2,3-DIFLUOROBENZENE; 2,3-DIFLUOROPHENETOL; DIPHOL	441-000-4	121219-07-6	Acute Tox. 4
3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt	440-770-9	371921-63-0	Eye Dam. 1
(2-methylpropyl)lithium; isobutyllithium	440-620-2	920-36-5	Water-react. 1; Pyr. Liq. 1; Skin Corr. 1A; STOT SE 3
reaction mass of: 3-[3-carbamoyl-5-(5-{4-chloro-6[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2oxo-1-pyridyl]propanoicacid, disodium salt	440-510-4	-	Eye Dam. 1; Skin Sens. 1
trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate	440-480-2	341026-59-3	Eye Dam. 1; Skin Sens. 1
tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate	440-460-3	252579-81-0	Eye Irrit. 2
2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan	440-030-5	338735-71-0	Skin Irrit. 2; Eye Dam. 1
reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)	439-540-0	-	Skin Irrit. 2; Skin Sens. 1
3,3,4,4-tetrafluoro-4-iodo-1-butene	439-500-2	33831-83-3	Acute Tox. 4; Skin Irrit. 2
(2,3-dimethylbut-2-yl)-trimethoxysilane	439-360-2	142877-45-0	Skin Irrit. 2; Eye Dam. 1
4-formylphenylboronic acid	438-670-5	87199-17-5	Skin Sens. 1
2-methyl-5-tert-butylthiophenol	438-520-9	7340-90-1	Flam. Liq. 3; Repr. 2; STOT RE 2; Asp. Tox. 1; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1; STOT SE 3
reaction mass of: triammonium; 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate	438-310-7	-	Self-react. C; Repr. 2; Acute Tox. 4; STOT RE 2
N-ethyl-3-trimethoxysilyl-2-methyl-propanamine	437-720-3	227085-51-0	Eye Dam. 1
pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate	436-920-8	172399-10-9	Eye Dam. 1
reaction mass of trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate	436-890-6	-	Eye Dam. 1
S-(3-(triethoxysilyl)propyl)octanethioate	436-690-9	220727-26-4	Skin Sens. 1
reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate	435-960-3	-	Carc. 1B; Muta. 1B; Skin Sens. 1
N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide	435-860-1	214417-91-1	Skin Sens. 1
alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts	435-660-2	243662-67-1	Skin Irrit. 2; Skin Sens. 1
alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride	435-650-8	-	Acute Tox. 4; Skin Corr. 1A
methyl-5-nitrophenyl-guanidine	435-500-1	152460-07-6	Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
N, N-(dimethylamino)thioacetamide hydrochloride	435-470-1	27366-72-9	Repr. 1B
reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)	435-450-0	5460-63-9	Skin Sens. 1
reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2yl]amino]benzoic acid; 3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid	435-440-6	-	Eye Dam. 1
sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid	435-350-7	141250-43-3	Eye Dam. 1
reaction mass of:5-endo-butyl-bicyclo[2.2.1]hept-2-ene; 5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)	435-180-3	-	Asp. Tox. 1; Skin Irrit. 2
2-chloro-N-(4-methylphenyl)acetamide	435-170-9	16634-82-5	Eye Dam. 1; Skin Sens. 1
ethyl 6,8-dichlorooctanoate 6,8-DICHLORETHYLCAPRYLAT; ETHYL-6,8 DICHLORO OCTANOATE	435-080-1	1070-64-0	Skin Sens. 1
N, N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine	435-010-8	26157-73-3	Muta. 2
5-endo-hexyl-bicyclo[2.2.1]hept-2-ene	435-000-3	22094-83-3	Asp. Tox. 1; Skin Irrit. 2
(S)-3-hydroxy-γ-butyrolactone	434-990-4	7331-52-4	Skin Sens. 1
2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one	434-820-9	106461-41-0	STOT RE 2
ethyl N2-dodecanoyl-l-argininate hydrochloride	434-630-6	60372-77-2	Eye Dam. 1
1-amino-2-methyl-2-propanethiol hydrochloride	434-480-1	32047-53-3	Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane	434-420-4	-	Skin Irrit. 2; Eye Dam. 1
sodium 2-(nonanoyloxy)benzenesulfonate	434-360-9	91125-43-8	Eye Dam. 1; Skin Sens. 1
O-isobutyl-N-ethoxy carbonylthiocarbamate	434-350-4	103122-66-3	Flam. Liq. 3; Carc. 1B; Muta. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1
reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide; 2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide; 2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide	434-330-5	-	Carc. 2; Skin Sens. 1
reaction mass of: (1RS, 2SR,7SR, 8SR, E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one	434-290-9	249630-78-2	Acute Tox. 4
2-cyclopentylidene cyclopentanol 1,1'-bi(cyclopentyliden)-2-ol	434-270-1	6261-30-9	Skin Irrit. 2; Eye Dam. 1
reaction mass of: mono-and di-glycerols of canola oil; canola oil acid amide of branched 1,3-propanediamine, N-[3-(tridecyloxy)-propyl]; N, N-diorgano dithiocarbamate molybdenum complex	434-240-6	-	Skin Sens. 1
1-imidazol-1-yl-octadecan-2-ol	434-120-3	1380001-48-8	Skin Sens. 1
2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate	433-910-5	145153-52-2	Skin Sens. 1
3-methyl-5-phenylpentan-1-al	433-900-0	55066-49-4	Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1
2-chloro-6-fluoro-phenol	433-890-8	2040-90-6	Muta. 1B; Repr. 2; Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
reaction mass of: potassium o-toluenephosphonate; potassium m-toluenephosphonate; potassium p-toluenephosphonate	433-860-4	-	Eye Irrit. 2; Skin Sens. 1
(2R, 3S, 4R, 5R, 7R, 9R, 10R,11S, 12S, 13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane	433-820-6	118058-74-5	Eye Irrit. 2
tripropylammonium dihydrogenphosphate TRYPROPYLAMMONIUM DIHYDROGENPHOSPHAT	433-700-3	35687-90-2	Acute Tox. 4
[3-(chlorocarbonyl)-2-methylphenyl]acetate	433-690-0	167678-46-8	Skin Corr. 1A; Skin Sens. 1
reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride(or sulfonicacid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol	433-640-8	-	Pyr. Sol. 1
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride [containing < 0,1 % 4-chloroaniline (EC No 203-401-0)];1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride [containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]	433-580-2	214353-17-0	Acute Tox. 4; Skin Corr. 1B
1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride [containing < 0,1 % 4-chloroaniline (EC No 203-401-0)];1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride [containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]	433-580-2	214353-17-0	Carc. 1B; Acute Tox. 4; Skin Corr. 1B
androsta-1,4,9(11)-triene-3,17-dione	433-560-3	15375-21-0	Repr. 2
5-acetoxy-2-(R, S)butyryloxymethyl-1,3-oxathiolane	433-530-1	143446-73-5	Acute Tox. 4; Skin Sens. 1
(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate	433-520-5	82911-69-1	Acute Tox. 4; Skin Sens. 1
(6β)-6,19-epoxyandrost-4-ene-3,17-dione	433-490-3	6563-83-3	Skin Sens. 1
clothianidin (ISO); (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine	433-460-1	210880-92-5	Repr. 2; Acute Tox. 4; STOT SE 1
2-butanone-O, O',O''-(phenylsilylidyne)trioxime	433-360-6	34036-80-1	STOT RE 2; Skin Sens. 1
(S)-azetidine-2-carboxylic acid; 4-cyanobenzylamide hydrochloride	433-010-2	2135910-74-4	Acute Tox. 4; Skin Sens. 1
disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate	432-980-4	243858-60-8	Eye Dam. 1
D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R, 6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate	432-960-5	124655-09-0	Acute Tox. 4
dimethyl[2S, 2S']-6,6,6'6'-tetramethoxy-2,2'-[N, N'-bis(trifluoracetyl)-S, S'-bi(L-homocysteinyl) diimino]dihexanoate	432-860-1	255387-46-3	Skin Sens. 1
12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine	432-840-2	220926-97-6	Acute Tox. 4
reaction mass of: succinic acid; monopersuccinic acid; dipersuccinic acid monomethyl ester of succinic acid monomethyl ester of persuccinic acid dimethyl succinate glutaric acid monoperglutaric acid diperglutaric acid monomethyl ester of glutaric acid monomethyl ester of perglutaric acid dimethyl glutarate adipic acid monoperadipic acid diperadipic acid monomethyl ester of adipic acid monomethyl ester of peradipic aciddimethyl adipate hydrogen peroxide methanolwater	432-790-1	847871-03-8	Acute Tox. 4; Skin Corr. 1B; STOT SE 2
O-hexyl-N-ethoxycarbonylthiocarbamate	432-750-3	109202-58-6	Carc. 1B; Muta. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1
benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo)) bis-, potassium sodium salt; potassium sodium 3-[(E)-(6{3,4-dihydroxy-2-}(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate HWL-158	432-590-4	243869-48-9	Eye Irrit. 2
4-fluoro-3-trifluoromethylphenol	432-560-0	61721-07-1	Acute Tox. 4; Skin Corr. 1A; Skin Sens. 1
tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate	432-550-6	243858-01-7	Eye Dam. 1
3-N, N-bis(methoxyethyl)aminoacetanilide	432-530-7	24294-01-7	Acute Tox. 4
4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride	432-470-1	189012-93-9	Eye Dam. 1; Skin Sens. 1
reaction products of diisopropanolamine with formaldehyde (1:4)	432-440-8	220444-73-5	Carc. 2; Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
platinum(IV) nitrate/nitric acid solution	432-400-1	10102-09-7	Skin Corr. 1A
(-)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride	432-360-3	105813-13-6	Acute Tox. 4; Skin Sens. 1
methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate	432-350-9	81752-87-6	Skin Irrit. 2
dimethyl (2S)-2-hydroxysuccinate	432-310-0	617-55-0	Flam. Liq. 3; Eye Dam. 1; Skin Sens. 1
triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate	432-270-4	221354-37-6	Repr. 2; STOT RE 2
Potassium titanium oxide(K2Ti6O13)	432-240-0	12056-51-8	Carc. 2
reaction mass of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane	432-230-6	-	STOT RE 1; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)	432-200-2	1379679-02-3	STOT SE 3; Skin Irrit. 2; Eye Dam. 1
Reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid; ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate	432-190-1	182176-52-9	Acute Tox. 4; STOT RE 2; Eye Dam. 1
mepanipyrim; 4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine	432-140-7	110235-47-7	Carc. 2
reaction mass of: pentasodium; 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium - 4-amino-5-hydroxy-6-(E)-2-sulfonato-4-}2-(sulfonatooxy)ethylsulfonyl{phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate	432-100-9	-	Eye Dam. 1
1-(3-methoxypropyl)-4-piperidinamine	431-950-8	179474-79-4	Acute Tox. 4; Skin Corr. 1B
2-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid	431-930-9	43028-69-9	Acute Tox. 4; Skin Sens. 1
4,4'-oxybis(benzenesulfonylazide)	431-850-4	7456-68-0	Expl. 1.1; STOT RE 2
barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped	431-780-4	199876-46-5	Acute Tox. 4; STOT RE 2
dodecyldiphenyl phosphate	431-760-5	27460-02-2	Skin Irrit. 2
cyclohexadeca-1,9-diene	431-730-1	4277-06-9	Skin Irrit. 2; Skin Sens. 1
methyl 3-amino-2,2,3-trimethylbutyrate	431-720-7	90886-53-6	Skin Corr. 1B; Acute Tox. 4
1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate LUPEROX 570	431-610-9	68860-54-8	Org. Perox. D; Skin Sens. 1
benzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide	431-600-4	112226-61-6	Skin Sens. 1
N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide	431-530-4	1380226-29-8	Skin Corr. 1A; Skin Sens. 1
(Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid	431-520-1	64485-90-1	Flam. Sol. 1; Carc. 2
imidazo[1,2-b]pyridazin hydrochloride	431-510-5	18087-70-2	Acute Tox. 4; Eye Irrit. 2
3,4,3', 4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione	431-500-0	226065-73-2	Skin Sens. 1
1-(chlorophenylmethyl)-2-methylbenzene	431-450-1	41870-52-4	Skin Irrit. 2
reaction mass of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo[}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetate)	431-440-5	-	Eye Dam. 1
diethyl[(p-ethoxyanilino)methylene]malonate	431-430-0	103976-28-9	Acute Tox. 4
2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate	431-400-7	57374-49-9	Skin Sens. 1
(R, S)-2-butyloctanedioic acid 2-BUTYLOCTANEDIOIC ACID	431-210-4	50905-10-7	Eye Dam. 1
4-(cyanomethyl)-4-methylmorpholin-4-ium hydrogen sulfate	431-200-1	208538-34-5	Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
1-methyl-3-phenyl-1-piperazine	431-180-2	5271-27-2	Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance	431-120-5	-	Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine	431-060-1	153719-38-1	Acute Tox. 4; Skin Sens. 1
3-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide	431-030-6	163269-30-5	Acute Tox. 3; STOT RE 2; Eye Dam. 1
2-(7-ethyl-1H-indol-3-yl)ethanol 7-ETHYLTRYPTOPHOL	431-020-1	41340-36-7	Acute Tox. 4; STOT RE 2
1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate	431-010-7	154486-26-7	Acute Tox. 4; Eye Dam. 1
N, N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea	430-930-6	122886-55-9	Eye Dam. 1; Resp. Sens. 1
1-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone	430-920-1	73096-98-7	Acute Tox. 4; Eye Dam. 1
(2,6-xylyloxy) acetic acid	430-910-7	13335-71-2	Acute Tox. 4; Eye Dam. 1
(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid	430-900-2	192725-50-1	Eye Dam. 1
sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate	430-890-1	81992-66-7	Skin Sens. 1
4-hexadecyl-1-phenylpyrazolidin-3-one	430-840-7	202483-63-4	Skin Sens. 1
9-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene FLEUROXENE	430-830-2	26912-64-1	Skin Irrit. 2
3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one	430-820-8	114341-88-7	Acute Tox. 4; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
2-isobutyl-2-isopropyl-1,3-dimethoxypropane	430-800-9	129228-21-3	Skin Irrit. 2
(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)3-(hydroxymethyl)benzonitrile hemisulfate	430-790-6	-	Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile	430-780-1	103146-25-4	Acute Tox. 4; Skin Sens. 1
(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile	430-770-7	128173-52-4	Acute Tox. 4; Skin Sens. 1
(R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile	430-760-2	219861-18-4	Acute Tox. 4; Skin Sens. 1
(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin	430-730-9	-	Eye Dam. 1
bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate	430-700-5	10138-36-0	Skin Sens. 1
reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane; 1-(3-isopropylphenyl)-1-phenylethane; 1-(2-isopropylphenyl)-1-phenylethane	430-690-2	52783-21-8	Skin Irrit. 2
tetrapropan-2-yl (dichloromethanediyl)bis(phosphonate)	430-630-5	10596-22-2	Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
(2,4-diaminopteridin-6-yl)methanol hydrobromide	430-620-0	76145-91-0	STOT RE 2; Skin Sens. 1
2,2-dialkyl-4-hydroxymethyl1,3-dioxolane; reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5)	430-580-4	-	Skin Irrit. 2
(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole	430-560-5	180637-89-2	Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1
4-mesyl-2-nitrotoluene	430-550-0	1671-49-4	Repr. 2; Acute Tox. 4; Skin Sens. 1
2-bromomalonaldehyde	430-470-6	2065-75-0	Acute Tox. 4; Eye Dam. 1
(+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)	430-460-1	133636-82-5	Skin Corr. 1B; Skin Sens. 1
tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate	430-390-1	845730-14-5	Acute Tox. 4
N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-N-carboxyanhydride	430-360-8	84793-24-8	Eye Dam. 1; Skin Sens. 1
(S)-α-(acetylthio)benzenepropanoic acid BMS 187266-02; S-TIPAC	430-300-0	76932-17-7	Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate	430-280-3	844491-96-9	Skin Sens. 1
1,1,1,3,3-pentafluorobutane	430-250-1	406-58-6	Flam. Liq. 2
(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide PTH-AA	430-230-0	136522-17-3	Acute Tox. 4
ethyl (3R)-4-cyano-3-hydroxybutanoate	430-220-6	141942-85-0	Eye Irrit. 2
reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6',13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6', 13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate	430-200-7	-	Eye Dam. 1
reaction mass of: calcium bis(C10-14 branched alkyl salicylate); calcium bis(C18-30-alkyl salicylate); calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate; calcium bis (C10-14 branched alkyl phenolate); calcium bis (C18-30-alkyl phenolate); calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate; C10-14 branched alkyl phenol; C18-30-alkyl phenol SP 7077	430-180-1	-	Skin Irrit. 2
2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one	430-170-5	114625-74-0	Acute Tox. 4
(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid	430-100-3	86978-24-7	Acute Tox. 4
sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate	430-090-0	205764-96-1	Eye Dam. 1; Skin Sens. 1
reaction mass of: N, N'-Ethane-1,2-diylbis(decanamide); 12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide; N, N'-Ethane-1,2-diylbis(12hydroxyoctadecanamide)	430-050-2	-	Skin Sens. 1
potassium ferrite	430-010-4	12160-44-0	Skin Corr. 1B; Skin Sens. 1
reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine; methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine; 2-isopropyl-N-hydroxyethyl 1,3-oxazolidine	429-990-6	-	Eye Dam. 1; Skin Sens. 1
6-glycidyloxynapht-1-yl oxymethyloxirane	429-960-2	27610-48-6	Muta. 2; Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1
(E)-3-methyl-5-cyclopentadecen-1-one	429-900-5	101151-17-1	Skin Sens. 1
reaction mass of: (1RS, 2RS,3SR, 6RS, 9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS, 2RS, 3RS, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde; (1RS, 2RS, 4SR, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde	429-860-9	86803-90-9	Skin Sens. 1
2-chloro-5-chloromethylthiazole 2-CHLORO-5-CHLOROMETHYLTHIAZOLE	429-830-5	105827-91-6	Acute Tox. 3; Skin Corr. 1B; Acute Tox. 4; Skin Sens. 1
guanidinium benzoate GUANIDINIUMBENZOAT	429-820-0	26739-54-8	Acute Tox. 4
(2-chloroethyl)(3-hydroxypropyl)ammonium chloride CLETOPROPAMINHYDROCHLORID	429-740-6	40722-80-3	Carc. 1B; Muta. 1B; STOT RE 2; Skin Sens. 1
lithium sodium 4,4', 4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate	429-730-1	193562-37-7	Eye Dam. 1; Skin Sens. 1
reaction mass of: 2,2'-dimethyl-2,2'-azobutanenitrile; 2-methylpentanenitrile-2-azo-2'-(2'-methylpropanenitrile); 2,2'-dimethyl-2,2'-azoheptanenitrile; 2-methylheptanenitrile-2-azo-2'-(2'-methylpropanenitrile); 2-methylheptanenitrile-2-azo-2'-(2'-methylbutanenitrile)	429-710-2	-	Self-react. D; Acute Tox. 4
ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate	429-680-0	122665-86-5	Skin Sens. 1
N, N'-bis(trifluoroacetyl)-S, S'-bis-L-homocysteine BMS 208143-01; BTHC	429-670-6	105996-54-1	Eye Dam. 1; Skin Sens. 1
reaction mass of: disodium hexyldiphenyl ether disulphonate; disodium dihexyldiphenyl ether disulphonate DOWFAX (R) DRY HYDROTROPE POWDER	429-650-7	147732-60-3	Eye Irrit. 2
N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine	429-640-2	52870-46-9	Eye Irrit. 2
reaction mass of: trans-trans-cyclohexadeca-1,9-diene; cis-trans-cyclohexadeca-1,9-diene	429-620-3	110028-14-3	Skin Irrit. 2; Skin Sens. 1
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate	429-610-9	1030366-98-3	Acute Tox. 4; Eye Dam. 1
2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)	429-600-4	1026988-42-0	Acute Tox. 4; Eye Dam. 1
reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol; 2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)ethoxy)ethanol; 3-(2,6-dichloro-4-nitrophenylazo)carbazol	429-590-1	-	Skin Sens. 1
monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate	429-570-2	213990-58-0	Skin Sens. 1
2-amino-4-(trifluoromethyl)benzenethiol hydrochloride	429-560-8	4274-38-8	Skin Corr. 1B; Acute Tox. 4; STOT RE 2; Skin Sens. 1
pyrazole-1-carboxamidine monohydrochloride	429-520-1	4023-02-3	Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1
2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one	429-460-4	7078-98-0	Skin Sens. 1
reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonate; 3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino{-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonic acid, sodium salt	429-440-5	-	Eye Dam. 1

Showing 201 - 400 of 4,691 results.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 14 May 2024. Database contains 4691 unique substances/entries.

Footer Nav Items